0 items USD 0.00Search
Your search for "delveinsight nonalcoholic steatohepatitis nash market insights epidemiology market forecast 2023" gave back 1591530 results.
The global Non-Alcoholic Steatohepatitis (NASH) Treatment market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030,...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
Nonalcoholic steatohepatitis is a form of liver disease that develops in patients who are not alcoholic. The major feature in NASH is fat deposition...
Catalog:
MRRPB5
April 2023
Price: USD 2,900.00
Highlights The global Non-Alcoholic Steatohepatitis (NASH) Treatment market was valued at US$ million in 2022 and is anticipated to reach US$ million...
Catalog:
MRRPB5
February 2023
Price: USD 2,900.00
In the context of China-US trade war and COVID-19 epidemic, it will have a big influence on this market. Non-alcoholic Steatohepatitis (NASH)...
Catalog:
9Dimen Research
May 2021
Price: USD 3,200.00
Non-alcoholic steatohepatitis (NASH) is a form of liver disease characterized by inflammation and liver cell damage caused by the accumulation of fat...
Catalog:
MRRPB5
September 2023
Price: USD 2,900.00
The global Non-alcoholic Steatohepatitis market size was valued at US$ 2476.9 million in 2023. With growing demand in downstream market, the Non-...
Catalog:
LPI
March 2024
Price: USD 3,660.00
Non-alcoholic steatohepatitis (NASH) is an advanced form of non-alcoholic fatty liver disease (NAFLD). NAFLD is caused by buildup of fat in the liver...
Catalog:
MRRPB5
September 2023
Price: USD 2,900.00
Non-alcoholic steatohepatitis (NASH) is an advanced form of non-alcoholic fatty liver disease (NAFLD). NAFLD is caused by buildup of fat in the liver...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
Mitogen Activated Protein Kinase Kinase Kinase 5 - Pipeline Review, H1 2020 Summary Mitogen Activated Protein Kinase Kinase Kinase 5 (Apoptosis...
Catalog:
Global Markets Direct
February 2020
Price: USD 3,500.00
Mitogen Activated Protein Kinase Kinase Kinase 5 - Pipeline Review, H2 2019 Summary Mitogen Activated Protein Kinase Kinase Kinase 5 (Apoptosis...
Catalog:
Global Markets Direct
December 2019
Price: USD 3,500.00
Summary Publisher estimates that the Nonalcoholic Steatohepatitis (NASH) market size will grow from xxx Million USD in 2020 to xxxx Million USD by...
Catalog:
HYR
June 2021
Price: USD 2,000.00
Summary HeyReport estimates that the Nonalcoholic Steatohepatitis (NASH) market size will grow from xxx Million USD in 2020 to xxxx Million USD by...
Catalog:
HYR
January 2021
Price: USD 2,000.00
“Non-alcoholic steatohepataitis (NASH) Pipeline Analysis” gives comprehensive insights on the various drugs being developed for the treatment of NASH...
Catalog:
IQ4I
August 2018
Price: USD 3,600.00
“Non-alcoholic steatohepataitis (NASH) Pipeline Analysis” gives comprehensive insights on the various drugs being developed for the treatment of NASH...
IQ4I
October 2019
Price: USD 3,600.00
Non-alcoholic steatohepatitis (NASH) is an advanced form of non-alcoholic fatty liver disease (NAFLD). NAFLD is caused by buildup of fat in the liver...
Catalog:
LPI
February 2023
Price: USD 3,660.00
